SCHEMBL1007938

SCHEMBL1007938

O=S(=O)(O)CCN1CCN(CCO)CC1.O=S(=O)(O)CCN1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CXCR4 P61073 2/20 0.35
LOX P28300 2/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 2/20 0.33
ANPEP P15144 1/20 0.33
ERAP2 Q6P179 1/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
HSD11B1 P28845 1/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2511955 1.00 ALDH1A1 (0.37) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL3294493 1.00 ALDH1A1 (0.37) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL28248770 0.98 POLB (0.37) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
Ethane SCHEMBL17593441 0.97 ALDH1A1 (0.37) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL27719314 0.95 HSD17B10 (0.37) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL108942 0.95 ALDH1A1 (0.36) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL8412336 0.95 ALDH1A1 (0.34) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
Hydrochloric Acid SCHEMBL632500 0.94 ALDH1A1 (0.35) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL28478814 0.93 POLB (0.38) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10
SCHEMBL7618304 0.93 POLB (0.41) ALDH1A1KDM4EPOLBSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386980-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon Inc. (US) 2018-10-17 EP disclosed
WO-2017100201-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2017-06-15 WO disclosed
WO-2017019804-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2017-02-02 WO disclosed
US-7932405-B2 Halogenated ester derivatives of coumarins for the treatment of coagulation disorders ARYX THERAPEUTICS, INC. (US) 2011-04-26 US disclosed
EP-2297140-A1 NOVEL 1,2,4 OXADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF Abbott Laboratories (US) 2011-03-23 EP disclosed
WO-2011028733-A1 COMPOSITIONS AND MINIMALLY INVASIVE METHODS FOR TREATING CANCER MISHRA ALLAN (US) 2011-03-10 WO disclosed
EP-2268244-A1 PERMEANT DELIVERY SYSTEM AND METHODS FOR USE THEREOF Altea Therapeutics Corporation (US) 2011-01-05 EP disclosed
EP-0912885-A1 METHOD AND APPARATUS FOR PERFORMING AUTOMATED ANALYSIS Abbott Laboratories (US) 1999-05-06 EP disclosed
WO-1998002727-A1 METHOD AND APPARATUS FOR PERFORMING AUTOMATED ANALYSIS ABBOTT LABORATORIES (US) 1998-01-22 WO disclosed
EP-0774113-A1 METHOD AND APPARATUS FOR PERFORMING AUTOMATED ANALYSIS Abbott Laboratories (US) 1997-05-21 EP disclosed
WO-1996004544-A1 METHOD AND APPARATUS FOR PERFORMING AUTOMATED ANALYSIS ABBOTT LABORATORIES (US) 1996-02-15 WO disclosed